These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16498780)

  • 1. [Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].
    Postavnyĭ VE
    Lik Sprava; 2005 Dec; (8):33-8. PubMed ID: 16498780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
    Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
    Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
    Koskenpato J; Färkkilä M; Sipponen P
    Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
    Pilotto A; Perri F; Leandro G; Franceschi M;
    Gerontology; 2006; 52(2):99-106. PubMed ID: 16508317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
    Francavilla R; Lionetti E; Castellaneta SP; Magistà AM; Boscarelli G; Piscitelli D; Amoruso A; Di Leo A; Miniello VL; Francavilla A; Cavallo L; Ierardi E
    Gastroenterology; 2005 Nov; 129(5):1414-9. PubMed ID: 16285942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
    Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
    Bianchi Porro G; Lazzaroni M; Bargiggia S; Maconi G; Trespi E; Perego M; Alvisi C; Villani L; Luinetti O; Fiocca R; Franceschi M; Cesana B; Solcia E
    Am J Gastroenterol; 1996 Apr; 91(4):695-700. PubMed ID: 8677931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CURCUMIN IN COMBINATION WITH TRIPLE THERAPY REGIMES AMELIORATES OXIDATIVE STRESS AND HISTOPATHOLOGIC CHANGES IN CHRONIC GASTRITIS-ASSOCIATED HELICOBACTER PYLORI INFECTION.
    Judaki A; Rahmani A; Feizi J; Asadollahi K; Hafezi Ahmadi MR
    Arq Gastroenterol; 2017; 54(3):177-182. PubMed ID: 28492711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
    J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coenzyme Q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxidation in chronic gastritis associated with H. pylori infection.
    Rahmani A; Abangah G; Moradkhani A; Hafezi Ahmadi MR; Asadollahi K
    J Clin Pharmacol; 2015 Aug; 55(8):842-7. PubMed ID: 25854786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to eradicate Helicobacter pylori using amoxicillin and omeprazole in the remnant stomach.
    Rino Y; Imada T; Kabara T; Takahashi M; Shiozawa M; Ohshima T; Hasuo K; Inaba M; Yoneyama K; Yoshikawa T; Yukawa H; Kawamoto M; Tokunaga M; Takanashi Y
    Hepatogastroenterology; 2003; 50(54):2267-9. PubMed ID: 14696514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quadruple therapy versus standard triple therapy for eradication of Helicobacter pylori in Kuwait.
    Alboraie M; Saad M; Al-Ali J; Malik M; Asem N; Schmidt I; Alfadhli AA
    Arab J Gastroenterol; 2015; 16(3-4):131-5. PubMed ID: 26611765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori of the remnant stomach and its eradication.
    Rino Y; Imada T; Shiozawa M; Takahashi M; Fukuzawa K; Hasuo K; Nagano A; Tanaka J; Hatori S; Amano T; Kondo J
    Hepatogastroenterology; 1999; 46(27):2069-73. PubMed ID: 10430399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
    Khayat O; Kilani A; Chedly-Debbiche A; Zeddini A; Gargouri D; Kharrat J; Souissi A; Ghorbel AJ; Ben Ayed M; Ben Khelifa H
    Tunis Med; 2006 Jun; 84(6):340-3. PubMed ID: 17042205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.